Chugai Pharmaceutical Co., Ltd., specializing in prescription pharmaceuticals and based in Tokyo, is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Since the start of the strategic alliance with Roche in October 2002, Chugai has been actively involved in prescription pharmaceutical R&D activities in Japan and abroad as an important member of the Roche Group.


Specifically, Chugai is working to deliver innovative products with global applications, focusing especially on the disease areas of oncology, immunology, neuroscience system and bone and joint. In Japan, Chugai’s research facilities in Gotemba and Kamakura are collaborating to develop new pharmaceuticals and Ukima is conducting research for technology development for industrial production. Overseas, Chugai Pharma Europe and Chugai Pharma USA are engaged in clinical development activities in Europe and the United States of America respectively.